CNTX
Context Therapeutics amended charter to authorize 310 million shares
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
CNTX news
Latest 1 stories · newest Jun 26, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same CNTX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CNTX/newsSTART FREE